Global Yeast Infection Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Global Yeast Infection Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

  • Healthcare
  • Upcoming Reports
  • Sep 2024
  • Global
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Global Yeast Infection Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2024 –2031
Diagramm Marktgröße (Basisjahr)
USD 4.37 Billion
Diagramm Marktgröße (Prognosejahr)
USD 7.01 Billion
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Scynexis
  • Merck & Co.
  • Bayer AG
  • Astellas Pharma
  • Thermo Fisher Scientific

Global Yeast Infection Market Segmentation, By Pathogens (Candida Albicans, Candida Glabrata, Candida Rugosa, Others), Types (Vaginal Yeast Infection, Skin Yeast Infection, Throat Yeast Infection, Others), Treatment (Medical Treatment, Surgery), End User (Hospital, Clinics, Ambulatory Centers, Others) – Industry Trends and Forecast to 2031.

Yeast Infection Market

Yeast Infection Market Analysis

Surging cases of the yeast infection is estimated to drive the market’s growth across the globe. According to NCBI studies, in 2018, around 30%-50% of women had vulvovaginal candidiasis at least once in their lives. Moreover, in Asia Pacific, Candida species is the most frequent yeast infection. Consequently, the market is estimated to show substantial growth over the forecasted period.

Yeast Infection Market Size

Global yeast infection market size was valued at USD 4.37 billion in 2023 and is projected to reach USD 7.01 billion by 2031, with a CAGR of 6.10% during the forecast period of 2024 to 2031.

Report Scope and Market Segmentation       

Attributes

Yeast Infection Key Market Insights

Segmentation

  • By Pathogens: Candida Albicans, Candida Glabrata, Candida Rugosa, Others
  • By Types: Vaginal Yeast Infection, Skin Yeast Infection, Throat Yeast Infection, Others
  • By Treatment: Medical Treatment, Surgery
  • By End User: Hospital, Clinics, Ambulatory Centers, Others

Countries Covered

U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa

Key Market Players

Scynexis Inc., (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Astellas Pharma Inc., (Japan), Thermo Fisher Scientific Inc., (U.S.), Novartis AG (Switzerland), Abbott (U.S.), Catalent, Inc., (U.S.), bioMérieux (France), Pfizer Inc. (U.S.), AbbVie Inc., (U.S.), ALLERGAN (Ireland), Jubilant Pharmova Limited (India), Sanofi (France), and AstraZeneca (U.K), Bruker (U.S.), Brundavan Laboratories Ltd. (India),  Curia Global, Inc. (U.S.) and Corden Pharma (Germany)

Market Opportunities

  • Research and development in medical science
  • Introduction of new treatment options for yeast infections
  • Rise in the investments and financing

Yeast Infection Market Definition

Candidiasis, often known as yeast or fungus infection, is a parasitic ailment. It's a naturally occurring component in the human body. It can cause infection in some cases due to changes in the body's immune level. It can also affect the skin, mouth, and stomach. Yeast infection in the vaginal area is very prevalent among women. Rashes, swelling, redness, stinging, and burning are all symptoms of this infection. Yeast infection can be caused by a lack of immunity, poor cleanliness, or lifestyle disorders.

Yeast infection Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Growing Prevalence Of Diseases, Infections And Other Ailments

The factors such as the rise in the prevalence of autoimmune disease and yeast infection along with the development of new fungal infections is the most significant factor driving the growth for this market. The rise in the burden of ailments like the cardiovascular, gastrointestinal and other diseases are also expected to accelerate the overall growth of the market.

Furthermore, the improving economic conditions worldwide that enables access to the quality and improved healthcare are also expected to fuel market growth. Moreover, the rising awareness among the patients regarding the yeast infections also cushions the market’s growth within the forecasted period. The rising demand for antifungal drugs and government support for research and development are also projected to bolster the growth of the market.

Opportunities

  • Growing Investments and Advancements

Moreover, the financing for the administration of research and development in medical science combined with introduction of new treatment options for yeast infections are estimated to generate lucrative opportunities for the market. The investments in this region for the yeast infection market will further offer numerous growth opportunities for the market.

Restraints/Challenges

  • Issues Associated with Treatment

On the other hand, issues during treatments and various treatment-related side effects are expected to obstruct market growth.

  • Other Limitations

Also, the concerning issues related to the drug resistance for the disorder and the incidents of unmet clinical needs are projected to challenge the yeast infection market in the forecast period of 2024-2031.

This yeast infection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the yeast infection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Yeast infection Market

Healthcare industry was largely impacted by the outbreak of COVID-19 as financial load on the healthcare industry was enormous. The yeast infection market was largely negatively impacted by the outbreak of COVID-19.  The imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various operations, medicine development and production, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, led to limited industry expansion and financial volatility.

Moreover, the treatment for the yeast infection is hampered. The majority of the doctors are assigned for COVID patient care, according to an orthopedic medical magazine. The clinical drug market, on the other hand, is seeing an increase in research that will lead to various innovations, which will have a positive impact on the market for yeast infections. After COVID-19, the yeast infection market will have a diverse product offering. The market for vaginal yeast infections will increase at the fastest rate.

Yeast infection Market Scope

The yeast infection market is segmented on the basis of pathogens, types, treatment and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Pathogens

  • Candida Albicans
  • Candida Glabrata
  • Candida Rugosa
  • Others

On the basis of pathogens, the yeast infection market is segmented into candida albicans, candida glabrata, candida rugosa and others.

Types

  • Vaginal Yeast Infection
  • Skin Yeast Infection
  • Throat Yeast Infection
  • Others

On the basis of types, the yeast infection market is segmented into vaginal yeast infection, skin yeast infection, throat yeast infection and others.

Treatment

  • Medical Treatment
  • Surgery

On the basis of treatment, the yeast infection market is bifurcated into medical treatment and surgery.

End User

  • Hospital
  • Clinics
  • Ambulatory Centers
  • Others

On the basis of end user, the yeast infection market is segmented into hospital, clinics, ambulatory centers, others.

Yeast infection Market Regional Analysis

The yeast infection market is analyzed and market size insights and trends are provided by country, pathogens, types, treatment and end user as referenced above.

The countries covered in the yeast infection market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the yeast infection market because of the increase in the in yeast infection. Moreover, the rise in the number of cases of vaginal infections within the region.

Europe is expected to witness significant growth during the forecast period of 2024 to 2031 due to the high prevalence of yeast infection within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The yeast infection market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for yeast infection market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the yeast infection market. The data is available for historic period 2010-2020.

Yeast infection Market Share

The yeast infection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to yeast infection market.

Yeast infection Market Leaders Operating in the Market Are:

  • Scynexis Inc., (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Bayer AG (Germany)
  • Astellas Pharma Inc., (Japan)
  • Thermo Fisher Scientific Inc., (U.S.)
  • Novartis AG (Switzerland)
  • Abbott (U.S.)
  • Catalent, Inc., (U.S.)
  • bioMérieux (France)
  • Pfizer Inc. (U.S.)
  • AbbVie Inc., (U.S.)
  • ALLERGAN (Ireland)
  • Jubilant Pharmova Limited (India)
  • Sanofi (France)
  • AstraZeneca (U.K)
  • Bruker (U.S.)
  • Brundavan Laboratories Ltd. (India)
  • Curia Global, Inc. (U.S.)
  • Corden Pharma (Germany)

Latest Developments in Yeast infection Market

  • In December 2021, Cidara Therapeutics, Inc. and Mundipharma published positive topline data from the key ReSTORE Phase 3 clinical trial, which looked at the efficacy and safety of rezafungin, a once-weekly antifungal candidate, as a first-line treatment for candidemia and invasive candidiasis


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The market is segmented based on Segmentation, By Pathogens (Candida Albicans, Candida Glabrata, Candida Rugosa, Others), Types (Vaginal Yeast Infection, Skin Yeast Infection, Throat Yeast Infection, Others), Treatment (Medical Treatment, Surgery), End User (Hospital, Clinics, Ambulatory Centers, Others) – Industry Trends and Forecast to 2031. .
The Global Yeast Infection Market size was valued at USD 4.37 USD Billion in 2023.
The Global Yeast Infection Market is projected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2031.
The major players operating in the market include Scynexis , Merck & Co. , Bayer AG, Astellas Pharma , Thermo Fisher Scientific , Novartis AG, Abbott, Catalent , bioMérieux, Pfizer , AbbVie , ALLERGAN, Jubilant Pharmova Limited, Sanofi, AstraZeneca, Bruker, Brundavan Laboratories , Curia Global , Corden Pharma .
The market report covers data from the U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa.